Evaluation of the Health Impact of the National Diabetes Program in Paraguay
Abstract
The clinical evolution of a diabetic patient is linked to its compliance with non-pharmacological measures such as diet, physical activity, acquiring habits, medical controls and also with its pharmacological treatment.
In different Latin American countries such as the Republic of Paraguay, there are National Programs to provide free support and treatment to the diabetic population that mostly have vulnerable social conditions. However, the impact of these government policies is not routinely evaluated. In order to establish the achievements of a state diabetes program, the present study was carried out.
Methodology: This is a descriptive, cross-sectional study with an analytical stage.
Results: low adherence to non-pharmacological measures such as diet and physical activity was detected. A high percentage of patients were overweight (38%) or obese (46.5%). 75% of the population enrolled in this study did not comply with the program recommendations regarding the time and frequency of physical activities, nor they complied with the minimum 6 daily meals required. Only 37% of the patients had normal levels of glycated hemoglobin and 51.3% of them had pharmacological treatment adherence. Low compliance was observed in relation to regular medical examinations (which were under free coverage by the program) that are transposed in 22% of retinal studies and 60% in 24-hour urine analysis for the early detection of complications such as retinopathy and nephropathy.
Conclusion: Despite the economic and logistical efforts carried out by State programs in order to care of people with diabetes mellitus, data showed a low adherence of patients to the proposed pharmacological and non-pharmacological measures. A personalized follow-up strategy is necessary to improve treatment adherence and to obtain better therapeutic results.
Keywords: Diabetes, adherence, treatment measures, National Program
Downloads
References
2. Association A.D. Classification and diagnosis of diabetes: Standards of medical care in Diabetes. Diabetes Care. 2018; 41:13–27.
3. Ganasegeran K, Hor CP, Jamil MFA, et al. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia. Int J Environ Res Public Health. 2020; 17(16):5723.
4. Hu F.B. Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids. 2003; 38:103–108. doi: 10.1007/s11745-003-1038-4.
5. Wu Y., Ding Y., Tanaka Y., Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int. J. Med Sci. 2014;11: 1185–1200.
6. McCarthy M.I. Genomics, Type 2 Diabetes, and Obesity. N. Engl. J. Med. 2010; 363:2339–2350.
7. Wing R.R., Bolin P., Brancati F.L., Bray G.A., Clark J.M., et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369:145-154.
8. Marin GH, Risso P, Sbatella D, Haag G. Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation. Quality in Primary Care (2015)23(2):93-96.
9. Maciel O, Vera Z; Marin GH; Maidana M; Samaniego L, et al. Cost-Effectiveness of drug compliance in type 2 diabetes mellitus patients; B. M. Vrushabendra Swamy; Research Journal of Pharmaceutical, Biological and Chemical Sciences; 2018; 9(5) 1824-1829.
10. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999.
11. Ministry of Health & Social Welfare, Paraguay. National Program of Diabetes. 2020. Available in: http://www.mspbs.gov.py/diabetes/index.php?option=com_content& view=article&id . Last access: 18 December, 2020.
12. Hill-Briggs F, Adler N, Berkowitz S, Chin M., Gary-Webb T, Navas-Acien A, Thornton P, Haire-Joshu D. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care Jan 2021; 44 (1):258-279.
13. Diabetes Prevention Program Research Group Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study Lancet Diabetes Endocrinol, 2015; 3:866-875
14. Ajala O., English P. Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr, 2013; 97:505-516
15. M.E. Lean, W.S. Leslie, A.C. Barnes, N. Brosnahan, G. Thorn, L. McCombie, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial Lancet, 2017; 391:541-551
16. Wing R.R., Bolin P. , Brancati F.L. , Bray G.A. , Clark J.M. , et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 2013; 369:145-154
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.